| Ivan L Wolf, MD | |
|
961 Canal Street, Syracuse, NY 13210-1287 | |
| (315) 478-1977 | |
| (315) 475-2909 |
| Full Name | Ivan L Wolf |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 961 Canal Street, Syracuse, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457479560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 155170 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ivan L Wolf, MD 5074 Pine Valley Drive, Fayetteville, NY 13066 Ph: (315) 446-8129 | Ivan L Wolf, MD 961 Canal Street, Syracuse, NY 13210-1287 Ph: (315) 478-1977 |
News Archive
Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say.
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment.
Chiasma, Inc., a U.S. late-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application (NDA) for the marketing and sale of octreotide capsules, an oral drug proposed for the maintenance therapy of adult patients with acromegaly.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick announced the release of the proposed rule Thursday, offering insights into how the administration hopes to encourage doctors and hospitals to collaborate more closely to improve patient care.
› Verified 8 days ago
Michael A Wolfson, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 627 Bradford Pkwy, Syracuse, NY 13224 Phone: 315-449-1707 | |
Dr. Reza Hosseini, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 6712 Brooklawn Pkwy, Ste 204, Syracuse, NY 13211 Phone: 315-432-8899 Fax: 315-431-9528 | |
Dr. Joseph Monkofsky Jr., M.D.,M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5092 Bradbury Dr, Syracuse, NY 13215 Phone: 315-440-8970 Fax: 315-492-3585 | |
Michael B. Lax, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Irving Ave, Suite 200, Syracuse, NY 13210 Phone: 315-464-4686 Fax: 315-464-7106 |